logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
Z

Zev A. Wainberg

David Geffen School of Medicine at UCLA

71H-index
612Paper Count
2.5WCitation Count
Published Papers 165
Publication Date
logo
Impact of UGT1A1*28 polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial
errFuture Oncology
IF2.6
err2026-05-04
err0
PREAI
errMaen Abdelrahim; Gazala Khan; Hassan Hatoum; Alice Zervoudakis; Farshid Dayyani; Li Zhang; Jia Li; Fiona Maxwell; Eileen M. O’Reilly; Zev A. Wainberg; Andrea Bullock
errShare
errSave
Neoadjuvant stereotactic body vs conventionally fractionated radiation therapy for borderline resectable and locally advanced pancreatic cancer: a propensity score-matched analysis
errJournal of Gastrointestinal Surgery
IF2.4
err2026-04-01
err0
PREAI
errShimizu, Takayuki; Zheng, Serena; Maeda, Shimpei; Link, Jason; Deranteriassian, Aletta; Premji, Alykhan; King, Johathan; Girgis, Mark; Hines, Oscar Joe; Wainberg, Zev; Raldow, Ann; He, Jin; Burns, William; Narang, Amol; Qadan, Motaz; Castillo, Carlos Fernandez-Del; Lillemoe, Keith D.; Wo, Jennifer; Hong, Theodore; Donahue, Timothy R.
errShare
errSave
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial
errNature Communications
IF15.7
err2026-01-31
err0
errOAAI
errZev A. Wainberg; Jason M. Link; Alykhan Premji; Serena Zheng; Michael Srienc; McKensie Hammons; Shineui E. Kim; Luyi Li; Zeyu Liu; Olga Tsvetkova; Evan R. Abt; Lee Rosen; Stephen Kim; Jonathan King; O. Joe Hines; Mark Girgis; Saeed Sadeghi; Olga Olevsky; Deborah Wong; Lisa Yonemoto; Ann Marie Siney; Kim Kelly; Christine Kivork; Chi-Hong Tseng; Caius G. Radu; David W. Dawson; Timothy R. Donahue
errShare
errSave
First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial
errThe Lancet Oncology
IF0
err2025-12-22
err0
PREAI
errJong-Mu Sun; Yee Chao; Sung-Bae Kim; Sun Young Rha; Thomas R Jeffry Evans; Andrew H Strickland; Zev Wainberg; Ian Chau; Sharon Pelles-Avraham; Jaffer Ajani; Ritu Malhotra; Qingyuan Liu; Sijing Li; Edward Cha; Melania Kalaitzidou; Xiayu Huang; Simon Allen; Chih-Hung Hsu
errShare
errSave
Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial
errNature Medicine
IF50
err2025-10-18
err0
errOAAI
errYelena Y. Janjigian; Do-Youn Oh; Meredith Pelster; Zev A. Wainberg; Subhransu Prusty; Sandahl Nelson; Amy DuPage; Amy Thompson; Daniel O. Koralek; Edward Allan R. Sison; Sun Young Rha
errShare
errSave
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results
errNature Medicine
IF50
err2025-08-11
err0
errOAAI
errZev A. Wainberg; Colin D. Weekes; Muhammad Furqan; Pashtoon M. Kasi; Craig E. Devoe; Alexis D. Leal; Vincent Chung; James R. Perry; Thian Kheoh; Lisa K. McNeil; Esther Welkowsky; Peter C. DeMuth; Christopher M. Haqq; Shubham Pant; Eileen M. O’Reilly
errShare
errSave
Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial
errESMO Open
IF8.3
err2025-08-05
err0
errOAAI
errD. Melisi; T. Macarulla; C. De La Fouchardière; R.A. Pazo Cid; S.R. Chandana; I. Kiss; W.J. Lee; T.O. Goetze; E. Van Cutsem; A.S. Paulson; T. Bekaii-Saab; S. Pant; R.A. Hubner; F. Maxwell; L. Zhang; F. Benzaghou; E.M. O’Reilly; Z.A. Wainberg
errShare
errSave
FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction adenocarcinoma
errCancer Treatment Reviews
IF10.5
err2025-05-26
err0
errOAAI
errElizabeth C. Smyth; Kyoung-Mee Kim; Sun Young Rha; Zev A. Wainberg; Hayden Honeycutt; Erica Sommermann; Atsushi Ochiai
errShare
errSave
Gastric Cancer, Version 2.2025
errJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
err2025-05-01
err0
PREAI
errAjani, Jaffer A.; D'Amico, Thomas A.; Bentrem, David J.; Corvera, Carlos U.; Das, Prajnan; Enzinger, Peter C.; Enzler, Thomas; Gerdes, Hans; Gibson, Michael K.; Grierson, Patrick; Gupta, Garima; Hofstetter, Wayne L.; Ilson, David H.; Jalal, Shadia; Kim, Sunnie; Kleinberg, Lawrence R.; Klempner, Samuel; Lacy, Jill; Lee, Byrne; Licciardi, Frank; Lloyd, Shane; Ly, Quan P.; Matsukuma, Karen; McNamara, Michael; Merkow, Ryan P.; Miller, Aaron M.; Mukherjee, Sarbajit; Mulcahy, Mary F.; Perry, Kyle A.; Pimiento, Jose M.; Reddi, Deepti M.; Reznik, Scott; Roses, Robert E.; Strong, Vivian E.; Su, Stacey; Uboha, Nataliya; Wainberg, Zev A.; Willett, Christopher G.; Woo, Yanghee; Yoon, Harry H.; McMillian, Nicole R.; Stein, MaryElizabeth
errShare
errSave
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
errNATURE MEDICINE
IF50
err2025-04-10
err0
PREAI
errZhao, Shen; Cheng, Ying; Wang, Qiming; Li, Xingya; Liao, Jun; Rodon, Jordi; Meng, Xiangjiao; Luo, Yongzhong; Chen, Zhendong; Wang, Wei; Yi, Tienan; Li, Yongsheng; Yin, Yongmei; Xu, Huiting; Yu, Guohua; Mi, Yanjun; Fan, Yun; Wainberg, Zev A.; Wang, Xiang; Su, Cuiyun; Yu, Qitao; Lai, Shuzhen; Sun, Longhua; Zhuang, Wu; Wang, Xian; Yang, Jiacheng; Li, Yaling; Ge, Junyou; Li, Jin; Zhang, Li
errShare
errSave
S2303: phase II/III trial of paclitaxel plus ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
errFUTURE ONCOLOGY
IF2.6
err2025-03-01
err0
errOAAI
errSaeed, Anwaar; Colby, Sarah; Oberstein, Paul Eliezer; Duda, Dan G.; Park, Robin; Agarwal, Rajiv; Figueroa-Moseley, Colmar; Vaidya, Riha; Unger, Joseph M.; Guthrie, Katherine A.; Rocha, Flavio G.; Senthil, Maheswari; Safyan, Rachael A.; Wainberg, Zev A.; Iqbal, Syma; Chiorean, E. Gabriela; Philip, Philip A.
errShare
errSave
EDGE-Gastric Arm A1: Phase II study of domvanalimab (D), zimberelimab (Z), and FOLFOX in first-line (1L) advanced gastroesophageal (GE) cancer
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errRha, S. Y.; Oh, D-Y.; Pelster, M.; Wainberg, Z. A.; Sison, A.; Scott, J.; Nelson, S.; Wishengrad, D.; Rhee, J.; Nuyten, D. S. A.; Janjigian, Y. Y.
errShare
errSave
NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI 3
errNATURE REVIEWS CLINICAL ONCOLOGY
IF82.2
err2024-10-25
err1
errOAAI
errWainberg, Zev A.; M. O'Reilly, Eileen
errShare
errSave
Quemliclustat (CD73 Inhibitor) reduces adenosine-regulated NR4A gene expression and increases mPDAC inflammation in patients from the ARC-8 trial
errCANCER RESEARCH
IF16.6
err2024-09-15
err0
PREAI
errKim, Ji Yun; Wang, Ning; Weeder, Ben; Stagnaro, Enzo; Mrouj, Karim; Aquino, Jose; He, Xian; O'Reilly, Eileen M.; Pant, Shubham; Manji, Gulam A.; Wainberg, Zev A.; Rhee, Joon; Beagle, Brandon; DiRenzo, Daniel; Walters, Matthew J.; Kaplan, Angelo; Cho, Sean; Kabbarah, Omar
errShare
errSave
Safety, PK, immune activation, and clinical outcomes with RBS2418 treatment, an oral ENPP1 inhibitor, alone or in combination with pembrolizumab in advanced solid tumors
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errMarron, T.; Segar, J.; Berlin, J. D.; Boccia, R.; Spira, A. I.; Powderly, J.; Chen, C.; Wainberg, Z. A.; Schanzer, J. M.; Glenn, J.; Klumpp, K.; Csiki, I.; Misleh, J. G.
errShare
errSave
Combination treatment with TTX-030, a first-in-class anti-CD39 antibody, in patients with advanced pancreatic cancer
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errWainberg, Z. A.; Cha, Y.; George, B.; Grewal, J. S.; Merchan, J. R.; Mckean, M.; Soares, H. P.; Cruz, T. D.; Moesta, A. K.; Jahn, T. M.; Singhal, A. K.; Tribouley, C.; Kongpachith, S.; Afar, D. E.; Mitra, S.; Spigel, D. R.; Balaraman, R.
errShare
errSave
Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-09-01
err0
PREAI
errJeong, Hyehyun; Kim, Bum Jun; Lee, Choong-kun; Park, Inkeun; Zang, Dae Young; Choi, Hye Jin; Lee, Sang Soo; Park, Do Hyun; Song, Tae Jun; Oh, Dongwook; Moon, Sung-Hoon; Kim, Kyu-pyo; Wainberg, Zev; Ryoo, Baek-Yeol; Yoo, Changhoon
errShare
errSave
MK-2870-015: A phase III study of trophoblast antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) vs treatment of physician's choice (TPC) for previously treated metastatic gastroesophageal adenocarcinoma (GEA)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errWainberg, Z. A.; Van Cutsem, E.; Shitara, K.; Janjigian, Y. Y.; Oh, D-Y.; Xu, J.; Wu, S.; Bhaumik, S.; Bhagia, P.; Tabernero, J.
errShare
errSave
Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option
errFRONTIERS IN ONCOLOGY
IF3.3
err2024-08-13
err0
errOAAI
errPark, Haeseong; Klempner, Samuel J.; Chao, Joseph; Wainberg, Zev A.; Lukanowski, Mariusz; Chenji, Suresh; Bourke, Shannon; Chatterjee, Anindya; Lorenzen, Sylvie
errShare
errSave
WRN Helicase: Is There More to MSI-H than Immunotherapy?
errCANCER DISCOVERY
IF33.3
err2024-08-02
err0
PREAI
errWainberg, Zev A.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
T
Tak W. Mak
H-index: 181 · Papers: 1.6K
E
Eric Van Cutsem
H-index: 174 · Papers: 1.8K
C
Charles S. Fuchs
H-index: 171 · Papers: 1.7K
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
P
Philippe Moreau
H-index: 159 · Papers: 2.3K
View more